Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 32,013 | 27,626 | 32,121 | 27,253 | 23,238 |
| Cost of Goods | 13,111 | 11,189 | 13,177 | 12,134 | 10,735 |
| Gross Profit | 18,902 | 16,437 | 18,944 | 15,119 | 12,503 |
| Operating Expenses | 44,591 | 40,897 | 35,245 | 32,296 | 33,110 |
| Operating Income | -25,578 | -24,271 | -16,124 | -17,043 | -19,872 |
| Other Income | 2,175 | 2,376 | 2,658 | 2,834 | 3,003 |
| Pre-tax Income | -23,403 | -21,895 | -13,466 | -14,209 | -16,869 |
| Net Income Continuous | -23,403 | -21,895 | -13,466 | -14,209 | -16,869 |
| Net Income | $-23,403 | $-21,895 | $-13,466 | $-14,209 | $-16,869 |
| EPS Basic Total Ops | -0.53 | -0.49 | -0.16 | -0.33 | -0.39 |
| EPS Basic Continuous Ops | -0.53 | -0.49 | -0.16 | -0.33 | -0.39 |
| EPS Diluted Total Ops | -0.53 | -0.49 | -0.16 | -0.33 | -0.39 |
| EPS Diluted Continuous Ops | -0.53 | -0.49 | -0.16 | -0.33 | -0.39 |
| EPS Diluted Before Non-Recurring Items | -0.53 | -0.49 | -0.30 | -0.33 | -0.39 |
| EBITDA(a) | $-24,279 | $-23,284 | $-15,189 | $-14,630 | $-20,949 |